Abstract
Background SA is aiming to achieve herd immunity against Covid-19 by the first quarter of 2022. The success of the Covid-19 vaccination roll-out depends primarily on the willingness of the population to take the vaccines.
Aim This study examined the willingness to take the Covid-19 vaccine, along with the factors of concern, efficacy, and preferences of the individual which may increase the willingness to be vaccinated.
Setting This study was conducted at the University of the Witwatersrand, Johannesburg, amongst adult students and academic and professional staff.
Methods We conducted a cross-sectional online study from 27 July – 14 August 2021. We performed descriptive and inferential analysis to determine the factors associated with willingness to take the Covid-19 vaccine.
Results 2364 participants responded to a survey link and 82% were students, 66.8% were in the 18-29 years age band, females represented 64.0% and 49.2% were black people. 1965 (83.3%) were willing to receive a Covid-19 vaccine, the most preferred vaccines were Pfizer (41%) and J&J (23%), local pharmacy (29%) and GP (17%) were the preferred places for vaccination and the trusted sources of information on Covid-19 vaccines were the general practitioners (40.6%) and specialists (19,2%). Perceptions that vaccines are safe (aOR=31.56, 95%CI: 16.02-62.12 for affirmative agreement) and effective (aOR=5.92, 95%CI: 2.87-12.19 for affirmative agreement) were the main determinants for willingness to taking a COVID-19 vaccine
Conclusion It is imperative to reinforce the message of Covid-19 vaccine safety and efficacy and to include the GPs and the community pharmacies in the vaccination roll-out in SA.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human Research Ethics Committee of the University of Witwatersrand gave ethics approval (M210495) for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email: drbmodi{at}gmail.com
DP SAAFP membership number AFP4704
Email: Deidre.Pretorius{at}wits.ac.za
Email: joelmfrancis{at}gmail.com
Data Availability
All data produced in the present study are available upon reasonable request to the authors
